Oncolytic adenovirus therapy (Navigo Proteins/University of Ulm)

N/A

Report date: 2025/01/26 16:39:06

Base Information

Drug NameOncolytic adenovirus therapy (Navigo Proteins/University of Ulm)
Drug Alias NameN/A
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsHead and Neck NeoplasmsCarcinoma, Squamous Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUlm University
China Registration ClassN/A

Develop Information

Active CompaniesNavigo Proteins GmbHUlm University
Inactive CompaniesN/A
Active IndicationsHead and Neck NeoplasmsCarcinoma, Squamous Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A